|
|||||||
|
|
|
|||||
|
|
|||||||
Dear participants,
On behalf of the Organizing Committee, I have the pleasure to welcome you to the 7th Pan African Diabetes Study Group Congress in Casablanca.
We are very honored that this meeting is held Under the High Patronage of His Majesty MOHAMMED VI The King of Morocco who is always working for reinforcing cooperation between Morocco and other African countries, giving great importance to closer collaboration in the medical fields.
The PADSG scientific meeting brings together hundreds of people interested in research and cares of diabetes mellitus. Basic scientists, primary, secondary and tertiary care health professionals, and members of the pharmaceutical industry, gather around the comprehensive scientific program put together by the PADSG.
This regional and international meeting promises to give everyone involved in diabetes research, therapy and care a great opportunity to report on new developments in the field, exchange views and experiences, and discuss and debate the latest scientific issues.
Casablanca which is situated in the north west of Africa, is especially suited to host the first PADSG meeting of the third millennium. The weather in May is delightful and offers an excellent time to get to know this beautiful city and its magnificent surroundings.
Again, you are welcome to Casablanca and to the 7th PADSG Congress and we wish you a happy stay with us.
Jamal BELKHADIR, MD PhD
Chairman, Organizing Committee
WORDS OF WELCOME
It is my pleasure to welcome you to the 7th Congress of the Pan African Diabetes Study Group. We are privileged to have this meeting under the grand Patronage of His Majesty King Mohammed VI, King of Morocco who has kindly given his blessing to this meeting. I am also pleased that we are having this meeting in the ancient and picturesque city of Casablanca and that you have all taken the time to come to this Congress.
Diabetes, not too long ago, was said to be almost absent in Africa particularly rural Africa but we all know that it is beginning to take epidemic dimensions. The formation of this Study group about 10 years ago could not have been more apt. Since its inception the Study Group has been meeting in several cities in various parts of the African continent. It has been slowly matured over the years. Some of its landmark achievements have been the production of a Consensus Document on Type 2 Diabetes and the current preparation of a Consensus Document on Type 1 Diabetes.
The Local organising Committee has laid on a wonderful programme which I am sure we will all enjoy. Please take advantage of this. I also invite you to see the beautiful city of Casablanca in particular and the great country of Morocco in general.
I wish you a very enjoyable and successful attendance at this Congress.
DR. S.F. Kuku, MD PhD
President, PADSG
|
President |
Dr S. F. KUKU, Nigeria |
|
Deputy President |
Prof. S.N. DIOP, Senegal |
|
Vice President Northern Region |
Prof. J. BELKHADIR, Morocco |
|
Vice President Southern Region |
Dr M. CHESWA, |
|
Vice President Central Region |
Dr K. KUBI, Congo |
|
Vice President Western Region |
Prof. S.K. OWUSU, Ghana |
|
Vice President Eastern Region |
Prof. A.B.M. SWAI, Tanzania |
|
Special Duties |
Prof. T. JOHNSON, Nigeria |
|
Secretary General |
Prof M. ARAB, Egypt |
|
Assistant Secretary General |
Dr S. BAHENDEKA, Uganda |
|
Treasurer |
Prof. H. ELGHOMARI, Morocco |
|
Director of Research |
Dr B. SEYOUM, Ethiopia |
|
Member Northern Region |
Prof. M. BELHADJ, Algeria |
|
Member Western Region |
Dr F. OFEI, Ghana |
|
Member Eastern Region |
Dr K. RAMAIYA, Tanzania |
Prof. M. R. ABABOU, Morocco
Prof. M. ARAB, Egypt
Prof. M. BELHADJ, Algeria
Prof. J. BELKHADIR, Morocco
Prof. J.D. BENSOUDA, Morocco
Prof. S. N. DIOP, Senegal
Prof. F. DRAOUI, Morocco
Prof. H. ELGHOMARI, Morocco
Dr S.F. KUKU, Nigeria
Prof. H. LACHKAR, Morocco
Dr M. NACIRI, Morocco
Prof. K. NAGATI, Tunisia
Dr A. SAAD, Morocco
Wednesday May 23th, 2001
1400 - 1800 Registration
Thursday May 24th, 2001
08:30 - 09:15 STATE OF THE ART LECTURE - Room 1
SA1 The Diabetes Epidemic 2001 and beyond
Chair: J.D. Bensouda, Morocco - S. Kuku, Nigeria
Speaker: P.J. Lefebvre, Belgium
09:15 - 12:30 SYMPOSIUM I - Room 1
Microvascular complications of Diabetes (1)
Chair: M.A.K. Omar, Soutn Africa - M. Belhadj, Algeria
09:15 - 09:35 SM1 Recent Development in Management of Diabetic Retinopathy
A. Berraho, Morocco
09:35 - 09:55 SM2 Recent Development in Management of Diabetic Nephropathy
K.E. Mogensen, Danemark
09:55 - 10:15 SM3 Recent Development in Management of Diabetic Neuropathy
J.R. Attali, France
10:15 - 10:30 Panel Discussion
10:30 - 10:45 TEA BREAK
Microvascular Complications of Diabetes (2)
Chair: M. Arab, Egypt - M. Naciri, Morocco
10:45 - 11:00 SM4 The Management of Neuropathy in Uganda
S. Bahandeka, Uganda
11:00 - 11:15 SM5 The Management of Nephropathy in the Maghreb
M. Belhadj, Algeria
11:15 - 11:30 SM6 The Management of Retinopathy in Ethiopia
B. Seyoum, Ethiopia
11:30 - 12:00 Panel Discussion
12:00 - 12:30 SM7 Diabetic Education in Africa: a dream or reality?
J.C. Mbanya, Cameroon
09:15 - 10:30 Oral Session (1) - Room 2
Chair: F. Marouane, Morocco - Otieno C.F., Kenya
OP 01 09:15 Association of angiotensin converting enzyme gene insertion/deletion polymorphism with myocardial
Infarction in patients with type 2 diabetes mellitus. Seyoum B. (1), Berhanu P.(1,2), Estacio R.O. (1,2,3),
Raynolds M. (2), Esler A. (1), Schrier R.W. (1,2)
(1) Colorado Prevention Center, Denver, Colorado, USA.
(2) Department of Internal Medicine, University of Colorado Health Sciences center, USA. (3) Denver Health, Denver, Colorado, USA.
OP 02 09:25 Homa-based assessment of cell function and insulin sensitivity in native Ghanaians with varying degrees
of glucose tolerance. Amoah A. GB (1), Osei K. (2), Schuster D.P. (2), Gaillard T. (2)
(1) Diabetes Research Laboratory, Department of Medicine and Therapeutics, University of Ghana Medical School, Accra. Ghana. (2) Division of Endocrinology and Metabolism, Department of Internal Medicine, The Ohio State University Hospitals, Columbus, OH, USA.
OP 03 09:35 TNF-x? Leptin and insulin resistance (peripheral sensitivity) in type 2 diabetes.
Abdel-Aaty T. (1), Rizk M.M. (2)
(1) Departements of Internal Medicine and (2) Clinical Pathology Faculty of Medicine, Alexandria University, Egypt.
OP 04 09:45 Incidence of type 1 and type 2 diabetes (0 - 34 years at onset) in Benghazi, Libya.
O.A. Kadiki , Benghazi, Libya.
OP 05 09:55 Prevalence of type 2 diabetes mellitus and glucose tolerance in the Setif area (Algeria).
Malek R. (1), Belateche F. (2), Laouamri S. (3), Hamdi-Cherif M. (3), Touabti A. (4), Bendib W. (1), Nechadi A. (1), Mekideche F.Z. (1), Hanat S. (1).
(1) Service de médecine interne CHU Sétif. (2) Service d’épidémiologie et de médecine préventive CHU Hussein Dey Alger. (3) Service d’épidémiologie et de médecine préventive CHU Sétif. (4) Laboratoire central CHU Sétif, Algeria.
OP 06 10:05 Glycaemic control in Kenyan African patients with diabetes mellitus attending out-patient
diabetic clinic at Kenyatta National Hospital, Kenya.
Otieno C. F. (1), Kariuki M. (2), Ng'ang'a L. (1)
(1) Department of Medicine, P. O. Box 19676, Nairobi.
(2) Department of Ophthalmology, Kenyatta National Hospital, Nairobi, Kenya.
10:15 - 10:30 Pannel discussion
10:30 - 10:45 COFFEE BREAK
10:45 - 12:00 Oral Presentation - Session 2 Room 2
Chair: H. Lachkar, Morocco - S. Diop, Senegal
OP 07 10:45 The diagnosis of diabetes mellitus : A contest between three points ?
Alzaid A. and Sobki S.
Riyadh Armed Forces Hospital, Riyadh, Saudi Arabia.
OP 08 10:55 Diabetes in Saharian African : results of survey.
Bosseri S. and Tibe I.
Tripoli Medical Center, Libya.
OP 09 11:05 Epidémiologie de l’hypertension artérielle au cours du diabète. A propos d’une étude en Région Oranaise (Algeria). Cherrak A. et coll.
Service de Médecine Interne B, C.H.U Oran, Algeria.
OP 10
11:15 Prévalence de l'HTA dans une population diabétique
de l'est algérien.
Benabbas
Y.,
Bouguerba A., Kerrouaz N., Ali-Bouacida M., Roula D.Service de médecine interne, Unité de diabétologie,
CHU Benbadis, Constantine - Algeria.
OP 11 11:25 Néphropathie diabétique. A propos de 70 cas.
Khanfari N., Hachim K., Niang A., Doukkali O., Zahiri A., Fathi E., Benghalem M.G.,
Ramdani B., Zaïd D. Service de Néphrologie Hémodialyse CHUIbn Rochd Casablanca - Morocco.
OP 12 11:35 Les complications oculaires du diabète et leurs prises en charge.
Tnacheri-Ouazzani B., Tachfouti S., Benharbit M., Mohcine Z.
Service d’Ophtalmologie A - Hôpital des spécialités Rabat - Morocco.
OP 13 11:45 Impuissance érectile et diabète sucré. Arrar M.
Service de Médecine Interne A, CHU d'Oran, Algeria.
OP 14 11:55 La Biopsie rénale dans la néphropathie diabétique.
Niang A., Rochdi R., Hachem KH., Ramdani B., Zaïd D.
Service de néphrologie-hémodialyse CHU Ibn Rochd, Casablanca - Morocco.
14:30 - 17:15 SYMPOSIUM II - Room 1
Macrovascular Complications of Diabetes
Chair: J.C. Mbanya, Cameroun - P.J. Lefebvre, Belgium
14:30 - 14:50 SM8 Hypertension. A. Lakhdar, UK
14:50 - 15:10 SM9 Ischaemic Heart disease. J. Sraïri, Morocco
15:10 - 15:30 SM10 Diabetic Dyslipidemia. F. Amara, Egypt
15:30 - 16:00 Panel Discussion
16:00 - 16:30 Presentation the IDF book : Diabetes and Cardiovascular Complications
J.C. Mbanya, Cameroun
16:30 - 17:00 TEA BREAK
18:00 - 19:00 Official Opening Ceremony
Friday May 25th, 2001 - Room 1
08:30 - 09:15 STATE OF THE ART LECTURE
SA2 Implications of UKPDS in Diabetes Management in Africa
Chair: R. Kaushi, Tanzania - K. Nagati, Tunisia
Speaker: M.A.K Omar, South Africa
09:15 - 10:00 STATE OF THE ART LECTURE
SA3 New Treatments in Diabetes Mellitus
Chair: M.R. Ababou, Morocco - J.M. Ekoe, Canada
Speaker : Pierre De Meyts, Danemark
10:00 -10:30 TEA BREAK
10:30 - 12:45 SYMPOSIUM III - Room 1
Diabetic Foot
Chair: J.R. Attali, France - F. Ofei, Ghana
10:30 - 10:50 SM11 Epidemiology and Cost of the Foot Lesions in Africa
A. Lokrou, Ivory Coast
1050 - 11:10 SM12 Which Assessment doing ?
Albert G. B. Amoah, Ghana
11:10 - 11:30 SM13 Educational Aspects
J.M. Ekoe, Canada
11:30 - 11:50 SM14 Therapeutic Aspects
M. Arab, Egypt
11:50 - 12:45 Panel Discussion
10:30 - 12:30 SYMPOSIUM IV - Room 2
Nutrition and Diabetes
Chair: F. Amara, Egypt - A. Hafidi, Morocco
10:30 - 10:50 SM15 Antioxidant and African Diet
A.B.M. Swai, Tanzania
10:50 - 11:10 SM16 Nutrition - Arteriosclerosis and Diabetes
K. Nagati, Tunisia
11:10 - 11:30 SM17 Can Type 2 Diabetes be prevented by life style change ?
D. Levitt, South Africa
11:30 - 12:30 Panel Discussion
Poster Session Poster Exhibition
08:00 - 18:00
PP 01 Diabète de type 2 et hypertension artérielle : problèmes posés par la prise en charge. Malek R., Bekar F., Choukeir K., Ali Khodja C., Nechadi A., Bendib W. Service de médecine interne CHU Sétif, Algeria.
PP 02 Hyperinsulinemia is Differently Regulated in Obese versus Non-obese African Diabetic Patients.
Gulam-Abbas Z. (1) and Ahrén B. (2). (1) Abbas Medical Centre,
Dar es Salaam, Tanzania. (2) Department of Medicine, Lund University, Malmö, Sweden.
PP 03 Insulinothérapie du diabète type II en hospitalisation.
Hassani R., Ibnousoufiane N., Ababou M.R.
Service d'Endocrinologie, CHU de Casablanca, Morocco.
PP 04 Croyance et connaissance vis à vis du diabète. Diouri A., Ababou M.R.
Service d'Endocrinologie et Maladies Métaboliques, CHU Ibn Rochd, Casablanca, Morocco.
PP 05 Validité de la glycémie capillaire dans les enquêtes de dépistage.
Houti L. (1), Bessaoud K. (1), Medjaoui I.(2), Larbi D. (1), Dida A., Zeboudj N. (3), Belhadj M. (4)
(1)Laboratoire de Biostatistique, Faculté de Médecine d’Oran. (2) Laboratoire CNASS-Cité Lafontaine.
(3) MSP Oran, (4) Service de Médecine Interne B, CHU Oran, Algeria.
PP 06 Le diabète pancréatique d'origine éthylique à propos de deux cas.
Diouri A., Rais Z., El Ghomari H.
Service d'Endocrinologie et Maladies Métaboliques, CHU Ibn Rochd, Casablanca - Morocco.
PP 07 Généralisation du dépistage de la rétinopathie diabétique : quels moyens?
Chadli
A., Kebbou M., Ababou M.R.
Service
d'Endocrinologie et Maladies Métaboliques, CHU de Casablanca - Morocco.
PP 08 Facteurs étiologiques du diabète instable avec hospitalisations multiples. A propos de 6 cas.
Hassani R., El Alami R., Ababou M.R.
Service d'Endocrinologie et Maladies Métaboliques, CHU de Casablanca - Morocco.
PP 09 Gestational diabetes : 203 cases.
Benanane A., Saadi N., El Farouqi A., Chraïbi Ch. and Alaoui M.T.
Maternity des Orangers, Rabat, Morocco.
PP 10 Tuberculose et diabète : résultats préliminaires d'une étude prospective.
Ben Amor J., Bourkadi J.E, Marc K., Iraqi GH.
Hôpital Moulay Youssef, CHU de Rabat - Morocco.
PP 11 L'infection chez le diabétique.
Azzouz S. Service de diabétologie CHU Mustapha Alger, Algeria.
PP
12
Etude
de l'association obésité-diabète non insulinodépendant chez le Togolais.
Tossou K.,
Akouete ABI-CL.
CHU Lomé Tokoin, Togo.
PP 13 Diabetic macular edema
Belmekki M., Naoumi A., Benchrifa A.F., Berraho A.
Ophlmolmologic Department, Hospital of specialities, Rabat, Morocco.
PP 14 Interest of the vitrectomy in complicated diabetic retinopathy.
Belmekki M., Knadry S., Boulanouar A., Agnaou L., Berraho A.
Ophlmolmologic Department, Hospital of Specialities, Rabat, Morocco.
PP 15 Les kératites neuro-paralytiques au cours du diabète. A propos de deux observations.
Lamrani R., Benkirane N., Benabdallah W., Chaoui Z., Berraho A.
Service d'Ophtalmologie B, Hôpital des Spécialités, CHU de Rabat, Morocco.
PP 16 Evaluation d'un enseignement de l'examen neurologique du patient diabétique chez l'étudiant en médecine.
Ibnousoufyane N., Tounsi H., Ababou M.R.
Service d’Endocrinologie et Maladies Métaboliques, CHU de Casablanca, Morocco.
Tounsi H., Koraichi S., Sekkat S., Fellah H., Benkhalek T., Bjani A., Ababou M.R., Benslimane A.
1. Service d’Endocrinologie et Maladies Métaboliques, CHU de Casablanca, Morocco.
2. Service d’Immunologie, Faculté de Médecine et de Pharmacie, Casablanca, Morocco.
PP 18 Foot Onychomycosis with diabetic patients. A prospective study on 60 cases.
Slaoui Z. (1), Youssouf M.(2), Kebbou M. (1), El Ghomari H. (1), Guessous Idrissi N. (2), Diouri A. (1), Ababou M.R.(1)
(1) Department of endocrinology and study of diabetes
(2) Department of parasitology and mycology, University hospital Ibn Rochd, Casablanca, Morocco.
Saturday May 26th, 2001 - Room 1
08:30 - 09:15 STATE OF THE ART LECTURE
SA4 Genetics of Diabetes mellitus: the current perspective and its implications
Chair: J. Belkhadir, Morocco - A. Lokrou, Ivory Cost
Speaker: F. Vasseur, France
09:15 - 12:30 SYMPOSIUM V
Diabetes in Africa (1)
Chair: H. Elghomari, Morocco - D. Levitt, South Africa
09:15 - 09:45 SM18 Diabetes Trends in Africa
A. Motala, South Africa
09:45 - 10:15 SM19 Diabetes and its Vascular Complications in Africa: an Overview
S. Diop, Senegal
10:15 -10:30 TEA BREAK
Diabetes in Africa (2)
Chair: S. Kuku, Nigeria - A. Mukhtar, Sudan
10:30 - 11:00 SM20 Diabetic Education in North Africa
M.R. Ababou, Morocco
11:00 - 11:30 SM21 Delivery of Diabetes Health Care: a Multidisciplinary Approach
F. Ofei, Ghana
11:30 - 12:00 SM22 Consensus of Type 1 Diabetes in Africa
M. Arab, Egypt
12:00 - 12:45 Panel Discussion
09:15 - 12:45 SYMPOSIUM VI - Room 2
Type 1 Diabetes
Chair: A. Balafrej, Morocco - A. De Leiva, Spain
09:15 - 09:45 SM 23 Epidemiology of Type 1 Diabetes in Africa. O. Kadiki, Libya
09:45 - 10:15 SM 24 The Prevalence of anti-IA2 Antibodies in South African Blacks with type 1.
F. J. Pirie, A.A.Motala, M.A.K. Omar and Sathar M.A., South Africa
10:15 -10:30 TEA BREAK
10:30 - 11:00 SM 25 Center of diabetic children. A. Balafrej, Morocco
11:00 - 11:30 SM 26 National Program of Diabetes in Morocco.
F.Z. Mouzouni, A. Saad, J. Mahjour, Ministry of Health, Morocco
14:00 - 15:30 SYMPOSIUM VII - Room 1
Diabetes and Pregnancy
Chair: F. Marouan, Morocco - S. Chabchoub, Tunisia
14:00 - 14:30 SM27 New Diagnosis Criteria of Pregnancy and Diabetes " Recommandations of ADA".
De Leiva A., Spain
14:30 - 15:00 SM28 Diabetes pregnancy : 310 consecutive cases followed in the
Orangers Maternity of Rabat.
Saadi N., Benanane A., Kharmach, M., Hajoui S., Filali A., Chraïbi Ch., Alaoui M.T.,
Morocco
15:00 - 15:30 SM29 Diabetes and Pregnancy in Africa, R. Kaushi, Tanzania
15:30 - 16:00 Panel Discussion
14:00 - 15:30 Oral Session - Room 2
Chair: J. Mahjour, Morocco - Z. Gulam-Abbas, Tanzania
OP 15 14:00 Outcome of hospital admissions for diabetic foot lesions in an adult diabetes Population, Dar es Salaam, Tanzania.
Gulam-Abbas Z. (1), Lutale J.K. (1), Morbach S. (2)
(1) Muhimbili University College of Health Sciences, Dar es Salaam, Tanzania,
(2) Marienkrankenhaus Soest, Germany.
OP 16
14:10 The delays model in
diabetic foot ulcers : A strategy for care designs and evaluation in
Kenya.
Otieno C.F.
(1), Nyamu P.N. (2)
(1) Department of Medicine, P. O. Box 19676, Nairobi.
(2)
Department of Medicine, Kenyatta National Hospital, P. O. Box 20723, Nairobi,
Kenya.
OP 17 14:20 Evaluation à moyen terme de la fréquence et les facteurs favorisant les récidives des lésions du pied chez les diabétiques.
Diouri A., Slaoui Z., Ababou M.R.
Service d'Endocrinologie et Maladies Métaboliques, CHU de Casablanca, Morocco.
OP 18 14:30 Pied diabétique. Importance d'une unité de dépistage des pieds à risque.
Tounsi H., Ouzidane L., Ababou M.R.
Service d’Endocrinologie et Maladies Métaboliques, CHU de Casablanca, Morocco.
OP 19 14:40 Well-being and diabetes treatment satisfaction in Moroccan type 2 diabetic patients.
El Ghomari H. and Ababou M.R.
Endocrinology and metabolic Diseases, University hospital of Casablanca, Morocco.
OP 20 14:50 Does primary care for diabetes in South Africa meet national guidelines standards ?
Levitt N.S., Steyn K., Daniels A.D., Patel M., Lombard C., Zwarenstein M.F.
University of Cape Town and Medical Research Council, South Africa.
OP 21 15:00 Chirurgie de la cataracte chez le diabétique.
Lamrani R., Knadry S., Berbich O., Berraho A.
Service d'Ophtalmologie B, Hôpital des Spécialités, CHU de Rabat, Morocco.
OP 22 15:10 Microalbuminurie, facteurs de risque et complications cardiovasculaires chez le Diabétique Sénégalais.
Diop S.N., Sarr A., Ka-Cisse M., Ndour-Mbaye, Cisse A., P. M. Diagne P.M.
Clinique Médicale 2 – CHU de Dakar, Senegal.
OP 23 15:20 International Consensus on the Management and the Prevention of the Diabetic Foot.
Gulam-Abbas Z.
Muhimbili University College of Health Science/Abbas Medical Centre, Dar es Salaam, Tanzania.
FREE COMMUNICATIONS (Oral & Posters)
We announce the prize of the best free communication oral or poster : sponsorship of the full participation (travel, accommodations and registration fees) to the 8th PADSG Congress
17:00 General Assembly of PADSG
GUIDELINES FOR ABSTRACT SUBMISSION
NEW
METHOD
OF SUBMITTING ABSTRACT
You
may submit an abstract via the Internet by filling in the following abstract form. When
submitting your abstract via Internet (chu.cc.ibnsina@sante.gov.ma),
please do not send any paper copy to the Secretariat.
Submitting
your abstract via Internet will provide several advantages:
·
Immediate
confirmation that your abstract has been received
·
No
mailing or courier expenses
You
can also print your abstract on the original abstract form and according to the
instructions enclosed. Please send the abstract to Congress Secretariat:
·
Phone: 212. 37. 67. 52. 01 - 212. 37. 22. 80. 71. 97
·
Fax : 212. 37. 67. 51. 55
·
E-mail:chu.cc.ibnsina@sante.gov.ma
Please
note that photocopies, faxed abstracts or illegible abstracts will not be
considered for review.
Do
not fold the abstract form. The confirmation of receipt of the abstracts by the
Congress Secretariat will be mailed to the Presenting Authorsin March 2001.
Deadline
for submission of abstract:March 15th, 2001
Lay
out
and Content of the Abstract
1.Your
abstract must be fully contained within the space provided.
Use a printer that gives a distinct impression, preferably in Times New Roman, 11
pt.Do not diminish the text within the frame.
Fill in
the name of the Presenting Author with full address on the left hand side ofthe
form called "Name and address of presenting author for correspondence".
Type the title of the Abstract within the frame called title in lower case Type
the initial(s) and family name(s) of all co-authors with Institutions, City and
Country within the frame called co-authors as follows: De Sanctis, Boston
Hospital, Boston, USA.
2.
Organise theAbstract to include the following:
·
The purpose of
thestudy
·
Methodology
·
The results
obtained
·
The conclusion
reached (a statement like "the results will be discussed " is
insufficient)
·
Non-proprietary
(generic)
names of drugs, written in lower case are required
·
Names in
Latin should be underlined
·
A simple table or graph may be included.
3.
Note that:
·
References and
credits are not to be included in the abstract
·
The «co-authors»
street address, postal code, academic degrees or grant support should not be
stated
·
Abbreviations may be used after the first appearance of the full word for which
they stand
·
Standard
abbreviations may be employed in the text
·
Place special
or unusual abbreviations in parentheses after the full wording at the first time
it appears in the body of the text
·
Abstracts not
correctly prepared will not be considered for presentation and only abstracts
written in English and French will be accepted.
ORAL COMMUNICATIONS
Time
foresseen for every communication is 10minutes plus 5 minutes for the
discussion.
POSTER
SESSIONS
Posters
will be shown for the whole period of theCongress (from May 24 to May 26).
During
the poster exbibition the presence of one of the Authors for at least one hour is
requested (the time table will be specified in the final program).
The
posters must have the following sizes: cm 70 (base), cm 100 (height).
Deadline
for submission of abstract:March 15th, 2001
ELECTRONIC SUBMISSION
Situation:
The Kingdom
of Morocco is situated on the North West tip of Africa, with the Atlantic Ocean
on
one coast and the Mediterranean on the other. Morocco is easily accessible; it's
only 14 kilometers away from Europe across the strait of Gibraltar.
Political
Regime:Constitutional
Monarchy.
The King of Morocco is His Majesty MOHAMMED VI.
Religion:
Islam is
the State religion. Free exercise of Cult is guaranteed.
Sizeand
Population: Moroccocovers
an area of 710,850 Km2 with a population of 27 millions.
Climate:
Theaverage
temperature in Casablanca in May is:
·
Low 18 degrees
Celsius (64 degrees F)
·
High 30 degrees
Celsius (86 degrees F).
Language:
Arabicis
the official language, but local dialects are spoken in the mountains, French is
the most commonly used as second language, followed by Spanish and English.
Currency:
The Moroccan
currency is the Dirham (DH) (US $1 = 10.53 Dh.
Banking:
The Banks
and Bureau de change in Casablanca are open from 0815 to 1130 on the morning and
14h15 to 1700 on the afternoon, Monday through Friday.
Spindle:
GMT.
Electricity:
220 volt
is used generally, except in the region far from the city,110-125 is used.
Transportation
Networks: 80,000Km
of roads. 1,900 Km of railway lines.
Air
Routes: Morocco
has
its own national carrier, "Royal Air Maroc "www.royalairmaroc.com and
a private airline "Regional Airlines". All major international
airlines
fly to Morocco.
International
Airports: Airports
in
Morocco are under the authority of "Office National desAéroports" (www.onda.org.ma).
Ports:
The
main ports are Al Hoceima, Tanger, Kenitra, Mohammedia, Casablanca, El Jadida,
Safi, Essaouira, Agadir, Tantan, Laayoune, Ad'Dakhla, M'Diq and Asilah.
Entry
Requirements
- Passport and visa:
A
valid passport is required. A visa may also be necessary in some cases. It is
advisable to contact the nearest Moroccan Embassy or Consulate.
Customs:
Information regarding
custom's regulation can be obtained from Moroccan Embassies, Consulates or Local
Tourist Offices.
(E-mail:
visitmorocco@mbox.azure.net /
Web Site: www.tourism-in-morocco.com).
Vaccinations:
No Vaccinations
are required to visit Morocco.
Tourist
information: In
Morocco:
information is available at the Regional Offices of the Ministry of Tourism or at
the Local Tourist Offices.
Abroad:
The Moroccan National Tourist Office has branches in most capital cities.
Otherwise, tourist information can be obtained at the Moroccan Embassies or
Consulates.
(E-mail:
visitmorocco@mbox.azure.net /
Web Site: www.tourism-in-morocco.com).
Hotels:
Hotels are rated from one to five stars. Hotel prices are approved by the Ministry of
Tourism. The total bed capacity in classified hotels exceeds 90.000 beds.
Cuisine:
Moroccan cuisine
is one of the finest in the World. Salades ,couscous, pastilla, fish and other
sea food, pastries and infinite number oflocal specialities contribute to
the gastronomic delights.
Insurance:
Participants are
strongly recommended to insure against medical expenses, loss and accident
occurring during the Congress.
Time and Place of the Congress : The Congress will take place from Thursday, May the 24th, to Saturday, May the 26th, 2001 in the "Hayatt Regency Hotel", Place Mohamed V of Casablanca- Morocco.
Phone: (212.22) 26.12.34 - Fax : (212.22) 22.01.80
Congress
Venue :The "Hayatt
Regency Hot el" is situated in the center of Casablanca and is within walking
distance of many hotels, thus making it an ideal venue forany International
Congress.
Congress
Secretariat :
The Congress
Secretariat and registration desk are located on the ground floor. The
Secretariat is responsible for the registration and the sale of tickets for the
Social events. The Secretariat will be opened as follows:
·
Thursday 24/05/01 0800
- 1800 hrs
·
Friday 25/06/01 0800
- 1800 hrs
·
Saturday 26/06/01
0800 - 1400 hrs
NameBadges
:Your personal name
badge will give you access to the scientific sessions and the exhibition.
Participants not wearing the badges will not be admitted to any
sessions or exhibition area.
Courses
Language: The two
official languages of the course will be English and French. Simultaneous
translation will be available only for plenary sessions.
Breaks:
During
the tea and coffee breaks, tea and coffee together with light snack will be served
to all registered participants wearing a badge.
Meals: Buffet
lunch
will be provided for all the registered participants. Daily lunch tickets will be
provided in the Congress kit. Please note that the tickets are only redeem able
on the day indicated on them.
Registration
fees
Full
Participant:
On
or before 31 March 200
Member :
US$
120,00
Non
Member : US
$ 150,00
After31
March 2001 or on site : US $ 200,00
Accompanying
person :
US $100,00
Registration
Fee for Participants to the Congress Includes: